glp 1 dangers How Dangerous Is Gastroparesis? The promise and peril of

Trial data have shown decreases in serious cardiovascular complications, including cardiovascular mortality, nonlethal heart attacks, and nonfatal cerebrovascular accidents, among individuals with type 2 diabetes and pre-existing cardiovascular pathology or high cardiovascular risk [3,5,13,14,37]

As the food industry continues to innovate, the availability of alternative sugars is expanding, providing consumers with more choices than ever

2024;326:C1203C1211

The observed effect of food on empagliflozin pharmacokinetics was not considered clinically relevant and empagliflozin may be administered with or without food

Alternative Care Channels Partnerships with medical spas and wellness centers present new avenues for distribution, expanding reach beyond traditional healthcare settings